Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on August 4, 2026

Aug. 4, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Certara Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 4, 2026

Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases

Indeterminate GlobeNewswire

Aug. 4, 2026

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader

Indeterminate GlobeNewswire

Aug. 4, 2026

Encore Technologies Completes Oversubscribed Private Placement and Increases Strategic Investment in Solstar Space Company

Indeterminate GlobeNewswire

Aug. 4, 2026

Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs

Indeterminate GlobeNewswire

Aug. 4, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire

Aug. 4, 2026

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy

Indeterminate GlobeNewswire

Aug. 4, 2026

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Aug. 4, 2026

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2026 sowie Informationen zur Geschäftsentwicklung

Indeterminate GlobeNewswire

Aug. 4, 2026

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Descartes Introduces New AI-Powered Free Trade Intelligence (FTI) Solution to Help Reduce Trade Costs

Indeterminate GlobeNewswire

Aug. 4, 2026

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

Fusemachines Closes Up to $10.66 Million Investment at $4.20 per Share for Growth Capital from Existing Investor Meteora Capital

Indeterminate GlobeNewswire

Aug. 4, 2026

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Aug. 4, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics

Indeterminate GlobeNewswire

Aug. 4, 2026

Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för juli 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP

Indeterminate GlobeNewswire

Aug. 4, 2026

Die weltweit besten alternativen Reiseziele abseits des Massentourismus

Indeterminate GlobeNewswire

Aug. 4, 2026

The world's best travel “dupes” to avoid overtourism

Indeterminate GlobeNewswire